Registration | Schedule | Call for AbstractsHotel & Travel | Sponsor/Exhibit | Event Policies

  May 2 May 3May 4 | May 5 | May 6 | May 7


2022 AAOM Schedule | Day 3 | Thursday, May 5

Registration Desk Hours: 7:00 AM – 5:00 PM | East Mezzanine
Exhibitor Hours: 7:00 AM – 5:00 PM | Peabody Grand Ballroom C

Time Session Room
7:00 – 8:00 AM Continental Breakfast Peabody Grand Ballroom D–F
7:30 – 8:00 AM General Assembly Meeting Peabody Grand Ballroom A–B
8:00 – 9:30 AM

Plenary I: Evidence–based Medicine: the Pathway Forward.
Moderators: Dr. Ahmed S. Sultan and Dr. Alessandro Villa

Peabody Grand Ballroom A–B   
8:00 – 8:25 AM Evidence-based Medicine: Forging Ahead for Clinical – Care Quality Improvement

Eduard E. Vasilevskis, MD

This talk describes the current evidence-based medicine strategies to improve patient care outcomes.

Learning objectives:

  1. Define “quality in healthcare” and discuss the current evidence-based strategies to improve patients care outcomes.
  2. Highlight the current challenges in delivering quality healthcare.
  3. Explore practical approaches to lower costs while implementing clinical-care quality strategies
8:25 –  8:50 AM 

Evidence-based Molecular Mechanisms for Trigeminal Neuropathies: Bench-side to Bedside Data.
Eli Eliav, DMD, PhD

This talk focuses on the bench-side and bed-side investigations elucidating the underlying pathobiology of trigeminal neuropathies in which future interventional management modalities can be built on.

Learning Objectives:

  1. Provide an overview for the classification of trigeminal neuropathies.
  2. Demonstrate the current evidence-based molecular mechanisms and pathobiology for trigeminal neuropathies with focus on translational studies.
  3. Discuss how the current understanding of pathobiology may influence future therapeutic approaches.
8:50 – 9:15 AM 

Biologics for Oral Vesiculobullous Lesions: Evidence from Clinical Trials
Jane Setterfield, BDS DCH DRCOG MD FRCP

This talk provides a review for the latest biologics and targeted therapies for the management of oral autoimmune vesiculobullous conditions and elaborate on patient selection criteria that may help in achieving success of therapies. 

Learning objectives:

  1. Familiarize with the recent randomized clinical trials on the use of biologics for management of oral autoimmune vesiculobullousconditions.
  2. Understand the patient selection criteria essential for achieving successful therapy. 
  3. Recognize the side effects associated with the latest biologics used in oral medicine settings and discuss approaches to manage these side effects.
9:15 – 9:30 AM  Plenary 1: Panel Discussion
9:30 – 10:00 AM Morning Break Peabody Grand Ballroom Foyer West
10:00 – 11:00 AM

Samuel Charles Miller Lecture:  Oncology & Oral Medicine – Together ‘til Death Do Us Part 
Nathaniel Treister, DMD, DMSc
Moderator: Sook Bin Woo, DMD

Since the dawn of modern oncology and the introduction of cytoreductive chemotherapy, the oral cavity has been well-recognized as both a potential source of infection as well as a site for clinically impactful toxicity. With remarkable advances in the understanding of cancer biology and identification of specific targets and dysregulated pathways, there has been a paralleled exponential growth in novel mechanistically based therapies that have revolutionized outcomes for some cancer diagnoses, while also introducing new (and often unique) toxicities. As the field of oncology has evolved and increased in complexity, the interface with oral medicine has only become more deeply interconnected and important. This talk will provide an overview of the historical relationship between oncology and oral medicine and highlight how a series of contemporary advances have led to paradigm-shifts within the scope of clinical care.       

Learning Objectives:

  1. Review cancer biology, the principles of oncology, how cancer is treated, and the range of toxicities and side effects that cancer patients may experience.
  2. Appreciate how oral health can affect, and be affected by cancer therapies, and how this can impact quality of life and clinical outcomes.
  3. Recognize the important role that oral medicine specialists play in providing essential care, advancing the field of oncology, and improving the lives of cancer patients. 
Peabody Grand Ballroom A–B
11:00 – 12:00 PM

Lester Burket Award Lecture
Caroline Bissonnette
Yuanming Xu

Peabody Grand Ballroom A–B
12:00 – 1:30 PM Product Theater Continental Ballroom
Lunch on your own  
ABOM Diplomates Lunch Venetian Ballroom
Academic Fellowship Business Meeting/Affiliate Fellowship Business Meeting Galaxie  Room
1:30 – 2:30 PM AAOM Program Directors Committee Meeting Cockrell Room
1:30 – 3:00 PM OM Practice Session 1: Oral Medicine Practice after Specialty Recognition
Moderators: Dr. Piamkamon Vacharotayangul and Dr. David Dean
Peabody Grand Ballroom A–B
1:30 – 1:55 PM ADA and Oral Medicine: Fostering Collaboration 

This talk elaborates on the resources and support the ADA can provide to increase the visibility of the specialty of oral medicine and overcome some of the obstacles encountered in oral medicine clinical practice. 

Learning objectives:

  1. Summarize the resources available through the ADA to enhance the visibility of Oral Medicine as a dental specialty.
  2. Describe the ADA’s political efforts on behalf of member dentists/dental specialties and strategies for collaboration in legislative advocacy.
  3. Discuss opportunities for collaboration between the ADA and AAOM to strengthen Oral Medicine at a national level. 
1:55 – 2:20 PM Time for Expansion: Guide to Oral Medicine Residency Program Start-Up

Andres Pinto, DMD, MPH, MSC

This lecture sheds light on the need for establishing new training programs in Oral Medicine to overcome the looming shortage in the number of oral medicine practices and highlight how specialty recognition can be the launchpad for this expansion.

 Learning objectives:

  1. Demonstrate the scarcity of oral medicine practices across the USA despite the existing demand.
  2. Discuss the various constraints that may limit the establishment of new, and the expansion of existing, residency programs and how specialty recognition may help overcome some of these hurdles.
  3. Provide a guide for building the infrastructure for a training program and navigating the process of accreditation, marketing, and recruitment. 
2:20 – 2:45 PM  The “After Taste” of the Pandemic on Oral Medicine Practice
Lauren Patton, DDS, DABOM

The talk will highlight the lingering effect of the pandemic that warranted modifications in OM clinical practice and discuss the pros and cons of these changes along with their influence on both patients and practitioners.

Learning objectives:

  1. Summarize the challenges presented by COVID-19 pandemic and innovations in Oral Medicine practice which were employed in response to these challenges.
  2. Review innovations that are most likely to enhance clinical care beyond the pandemic.
  3. Discuss lingering challenges in clinical practice presented by the pandemic and where the specialty may go from here.
2:45– 3:00 PM OM Practice Session 1: Panel Discussion
3:00 – 3:30 PM Afternoon Break Peabody Grand Ballroom Foyer West
3:30 – 5:00 PM

Meet the Experts Sessions (Open Roundtable Discussions)
Moderators: Dr. Arwa Farag and Dr. Alessandro Villa

 





Building your OM practice: What Changed after Specialty Recognition? 
Joel Napenas, DDS & Jaisri Thoppay, DDS,MBA,MS
Moderator:  Joel Napenas

Gaining specialty recognition might have increased the visibility of oral medicine but also introduced a layer of complexity to clinical practice. Due to the unique, and unconventional, nature of this specialty, practitioners face many obstacles when it comes to developing their practices including credentialing, billing, and coding. Participants in this session will get the opportunity to engage in a discussion, with OM clinicians experienced in practice management, about the common practice challenges in credentialing, coding/cross-coding and billing and how specialty recognition might positively or negatively influence these challenges.

Lansdowne Room

Practice Pearls in Management of Patients with Neuropathic Orofacial Pain 
Eli Eliav, DMD, PhD
Moderator: David Dean

The complexity of orofacial pain can negatively impact the clinician’s ability to elucidate, diagnose, and manage the case. This session offers the opportunity to interact with top-tired experts in the field of orofacial pain and benefit from their knowledge and expertise in diagnosing and customizing care for complicated cases.

Barclay Room

Pediatric Oral Medicine: A Whole New World
Catherine Hong, BDS, Ms, FRCSEd  &  Kentaro Ikeda, DDS, MPH
Moderator: Jennifer Frustino

While many diseases in pediatric population are limited to the oral cavity, some are systemic conditions in which oral manifestations are one of the early constellations of findings. Attendees of this session will get the chance to engage in discussion with an expert in pediatric oral medicine and learn about the special diagnostic methods and treatment modalities that can be customized for pediatric patients.

Auburn Room

Oral Care for Hematology/Oncology Patients: A case-based discussion
Sharon Elad, DMD, MSc. & Noam Yarom, DMD
Moderator: Alessandro Villa

Oral complications from radiotherapy to the head and neck or chemotherapy can compromise patient health and overall quality of life and can affect their ability to complete the planned cancer treatment. Stemming out of a clinical case, this session will provide an in-depth discussion regarding the medical necessity of oral care before, during, and after cancer treatment to reduce the incidence and severity of oral complications and enhance both patient survival and quality of life.

Hawthorne & International Room

Oral Potentially Malignant Disorders: A Case-based Discussion
Saman Warnakulasuriya, BDS, FDSRCS (Eng), FDSRCS (Edin), FDSRCPS. (Glasg), PhD(Glasg), DSc, FKC & Sook-Bin Woo, DMD, MS
ModeratorPiamkamon Vacharotayangul

Patient oral and health and quality of life can be greatly impacted by oral disorders that have the potential for malignant transformation.  This session will demonstrate, with a clinical case, the importance of early detection of oral potentially malignant disorders and the role that oral health providers serve in managing these challenging cases.

Jackson Room

Salivary Glands Dysfunctions: A Case-based Discussion
Caroline Shiboski, DDS, MPH, PhD & Vidya Sankar, DMD, MHS
Moderator: Chelsia Sim

Salivary gland disorders and dysfunctions may play an important role in oral and systemic health. They arise from multiple etiologies including inflammatory, infectious and autoimmune conditions. Based on a clinical case, session attendees will explore the causes, diagnoses, and management strategies of salivary gland dysfunctions with a special focus on the most recent updates in Sjogren’s syndrome research.

Galaxie Room
5:00 – 7:00 PM

Poster Presentations Session

 Continental Ballroom

 

< Previous Day
Next Day >


May 2  | May 3May 4 | May 5 | May 6 | May 7

Sook-Bin Woo, DMD, Ms